Propeller Health is partnering with Aptar Pharma, a drug delivery system company, to create what the company believes will be the first-to-market integrated, connected metered dose inhaler (MDI).
PORTLAND, Ore., Nov. 26, 2025 /PRNewswire/ -- Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as asthma and chronic obstructive ...
NEW YORK, Dec. 5, 2017 /PRNewswire/ -- Future Market Insights offers 10-year forecast on the global respiratory inhaler devices market between 2017 and 2027. This study covers the market dynamics and ...
GSK plc announced positive phase III data from its clinical programme to develop a next-generation version of its metered dose inhaler (MDI), Ventolin (salbutamol). Data confirm that the formulation ...
"About three quarters of all inhalers used in the in this country are propellant-type inhalers," said Dr. Allison Burbank, a pediatric allergy and immunology researcher at UNC. Metered dose inhalers ...
Switching from a metered-dose inhaler to a dry powder version for maintenance therapy more than halves the carbon footprint of people with asthma, and without any worsening of their condition, finds a ...
NEW ORLEANS — Switching inhaler types due to insurance formulary changes may lead to reduced lung function in children with asthma, according to data presented at the CHEST Annual Meeting. “Insurance ...
Environmentalists now have a new cause to take up – the metered dose inhalers (MDIs) used by asthmatic patients to control their airway spasm. According to a new study from the University of Cambridge ...
What to do when a patient’s asthma control deteriorates after switching to a more environmentally friendly, or ‘greener’, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback